...
首页> 外文期刊>Analytical Chemistry >Technical and Biological Variation in UPLC−MS-Based Untargeted Metabolic Profiling of Liver Extracts: Application in an Experimental Toxicity Study on Galactosamine
【24h】

Technical and Biological Variation in UPLC−MS-Based Untargeted Metabolic Profiling of Liver Extracts: Application in an Experimental Toxicity Study on Galactosamine

机译:基于UPLC-MS的肝脏提取物非目标代谢谱分析的技术和生物学变化:在半乳糖胺的实验毒性研究中的应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT: The relative importance of technical versus bio-nlogical variation inUPLC-MS livermetabolic profiling studies wasnassessed on liver samples collected as part of an in vivo hepato-ntoxicity study. Biological variability within and between two treat-nment groups (three rats treated with galactosamine and three withngalactosamineþuridine) was compared with sampling/extractionnvariability (three portions extracted fromeach rat liver section) andnUPLC-MS platform variability (triplicate injections of eachnextract) for aqueous and organic extracts. The impact of scalingnon error measurement was investigated on replicate injections of a quality control sample, and consequently started log-transformation wasnused to stabilize the variance across the ion intensity range. For aqueous extracts, technical variability was two to four times lower than withinngroup interanimal variability. Similar results were obtained for organic extracts for the galactosamine group, sampling/extraction variabilitynbeing more elevated in the galactosamineþuridine group. For both extract types, differences between treatment groups were the principalnsource of observed variation, and triplicate injections clustered closely in PCA plots and in HCA dendrograms, indicating small instrumentnvariability compared to observed biological variation. This protocol can be applied to investigate differences in liver metabolic profilesnbetween animal groups in toxicology studies and clinical investigations of liver disease.
机译:摘要:对作为体内肝毒性研究一部分的肝脏样本进行了UPLC-MS肝代谢分析研究中技术与生物统计学差异的相对重要性。比较两个治疗组之间的生物学差异(三只半乳糖胺治疗的大鼠和三只半乳糖胺尿嘧啶尿苷)与采样/提取的可变性(从每只大鼠肝脏切片中提取三份)和nUPLC-MS平台的水性和有机物可变性(每针重复三次)提取物。研究了定标非误差测量对质量控制样品重复进样的影响,并因此开始对数转换,以稳定离子强度范围内的变化。对于水性提取物,技术变异性比n组动物内部变异性低2-4倍。半乳糖胺组的有机提取物获得了相似的结果,半乳糖胺þ尿苷组的采样/提取变异性更高。对于这两种提取物类型,治疗组之间的差异是观察到变异的主要来源,并且三次重复注射在PCA图和HCA树状图中紧密聚集,表明与观察到的生物学变异相比,仪器变异性较小。该方案可用于在动物毒理学研究和肝病临床研究中调查动物组之间肝脏代谢谱的差异。

著录项

  • 来源
    《Analytical Chemistry》 |2011年第3期|p.1116-1123|共8页
  • 作者单位

    †Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Sir Alexander Fleming Building, Imperial CollegeLondon, South Kensington, SW7 2AZ, U.K.‡Laboratory of ForensicMedicine and Toxicology, Faculty ofMedicine, Aristotle University of Thessaloniki, 54124 Thessaloniki,Greece;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号